NUZ 0.00% 22.5¢ neurizon therapeutics limited

Ann: FDA Provides Clear Feedback for ODD Approval, page-8

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 12,319 Posts.
    lightbulb Created with Sketch. 6325
    The FDA never believe the hype . It's a refined process.
    First 45 days Vetting ,
    next was processing but no data , none , can't process the application without supportive data , pretty simple...

    Great that the FDA have said they will keep open the application ,, I would say we have 10 to 15 working days to supply the Phase I/ II MND Data and then a complete resubmission will be required,, because its a stack that is being worked through from Companies that have supplied the supportive information and the FDA will not penalise them by taking up time to process an application that is incomplete and void of Data... NZT

    The question is 'Why has the Phase I/II data taken so long to analyse" ?
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.